HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Mortality of patients with ST-elevation acute myocardial infarction treated with primary angioplasty or thrombolysis].

AbstractBACKGROUND:
Primary angioplasty is the most effective treatment of ST-segment elevation acute myocardial infarction (STEMI). However, its worldwide implementation is difficult to obtain. Therefore thrombolysis continues to be the treatment most commonly used.
AIM:
To evaluate in-hospital and long term mortality of patients with STEMI treated with thrombolysis or angioplasty, in three hospitals participating in the Chilean National Registry of Acute MI (GEMI group).
MATERIAL AND METHODS:
Registry of 1,634 consecutive patients with STEMI admitted between 2002 and 2006. Risk was stratified using the Thrombolysis in Myocardial Infarction (TIMI) Risk Score. Hospital and log term mortalities were adjusted using logistic and Cox regression models.
RESULTS:
Fifty nine percent of patients (967 patients aged 60+/-12 years, 77% males) were subjected to reperfusion therapies, 28% with primary angioplasty and 72% with thrombolysis. Hospital mortality rates among patients treated with thrombolysis and angioplasty were 10.9% and 5.6% (p =0.01), respectively The figures for long term mortality were 20.4% and 9.7%, respectively (p <0.01). Multivariate analysis confirmed the lower mortality among subjects treated with angioplasty, with an odds ratio (OR) in favor of angioplasty of 8.5 (95% confidence intervals (CI) 3-35) for in hospital mortality and of 4.7 (95% CI 2.6-8.3) for long term mortality. The higher benefits of angioplasty were observed in males, in the elderly and in patients with a TIMI score over >3.
CONCLUSIONS:
Hospital and long term mortality of patients with STEMI was lower among those treated with primary angioplasty. This treatment is most beneficial among males, in the elderly and in patients with a TIMI score >3 .
AuthorsDouglas Greig, Ramón Corbalán, Pablo Castro, Pabla Campos, Rubén Lamich, Patricio Yovaniniz
JournalRevista medica de Chile (Rev Med Chil) Vol. 136 Issue 9 Pg. 1098-106 (Sep 2008) ISSN: 0034-9887 [Print] Chile
Vernacular TitleImpacto de la trombolisis y de la angioplastia primaria en pacientes con infarto agudo del miocardio tratados en centros hospitalarios terciarios.
PMID19030652 (Publication Type: English Abstract, Journal Article, Multicenter Study)
Chemical References
  • Fibrinolytic Agents
Topics
  • Adult
  • Age Distribution
  • Aged
  • Angioplasty
  • Female
  • Fibrinolytic Agents (therapeutic use)
  • Hospital Mortality
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (mortality, therapy)
  • Myocardial Reperfusion (methods)
  • Prospective Studies
  • Survival Analysis
  • Survival Rate
  • Thrombolytic Therapy
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: